ArticleInternational urogynecology journal2026
Prevalence and Impact of Pelvic Floor Dysfunction in a Large Cohort of Patients with Endometriosis: The Hidden Link.
Article in International urogynecology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
introduction and hypothesisEndometriosis may contribute to the onset of pelvic floor dysfunction (PFD) but data on urologic and bowel symptoms in endometriosis patients are scant. The aim of this study is to determine the prevalence of PFD in women with endometriosis and their impact on quality of life.
methodsThis is a cross-sectional study. A web survey was distributed throughout Italy from November 2022 to November 2023 to fertile age women with a self-reported diagnosis of endometriosis made by a specialist gynecologist or through surgery, assessing: medical history, pregnancies, endometriosis-related pain, urinary symptoms, bowel symptoms, sexual function, and quality of life. The informed consent was signed by 1149 women. Out of 820 eligible, 525 participants completed all questionnaires (64.0%).
resultsOf the participants, 440 (83.8%) had sexual dysfunction, 346 (65.9%) moderate/severe urinary symptoms, 348 (66.3%) moderate/severe bowel symptoms, 361 (68.8%) moderate to very severe constipation, and 404 (77.0%) mild symptoms of fecal incontinence. The reported symptoms were mainly indicative of high bladder and bowel sensitivity and voiding dysfunction. History of pregnancy did not affect urinary and bowel function, except for incontinence symptoms and rectal prolapse. Medical treatment or previous surgery for endometriosis were not associated with different urinary and bowel function scores. Urinary Distress Inventory 6 and Colorectal-Anal Distress Inventory 8 were correlated with a worse score in all domains of the Endometriosis Health Profile 30 (all rho > 0.28, p < 0.001).
conclusionsPFD is unexpectedly extremely common in women with endometriosis and affects sexual, urinary, and bowel function. This seems to be a potentially underestimated and underdiagnosed condition, with a severe negative impact on quality of life.
Indexed as
Identifiers
42671576What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.